Rafferty Asset Management, LLC Generation Bio Co. Transaction History

Rafferty Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$4.87 - $9.41 $54,251 - $104,827	-11,140 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$4.16 - $7.76 $430,044 - $802,197	-103,376 Reduced 90.27%	11,140 $82,000
Q4 2021 Feb 10, 2022	BUY	$5.99 - $24.97 $324,885 - $1.35 Million	54,238 Added 89.98%	114,516 $811,000
Q3 2021 Nov 10, 2021	SELL	$20.0 - $27.43 $542,920 - $744,614	-27,146 Reduced 31.05%	60,278 $1.51 Million
Q2 2021 Aug 10, 2021	SELL	$24.34 - $38.34 $205,697 - $324,011	-8,451 Reduced 8.81%	87,424 $2.35 Million
Q1 2021 May 10, 2021	BUY	$24.74 - $40.2 $2.37 Million - $3.85 Million	95,875 New	95,875 $2.73 Million

49.6M

Ticker GBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,011,200
Market Cap $44.8M
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.